Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangchuan Biotechnology, officially Shanghai Jiangchuan Biotechnology Co., Ltd., is a specialized biotechnology firm focused on the development and production of high-quality raw materials for the In Vitro Diagnostics (IVD) industry. Established in 2015 and based in Shanghai, the company provides a comprehensive portfolio of monoclonal antibodies, polyclonal antibodies, and recombinant antigens essential for diagnostic assays. Their product range covers critical clinical areas including infectious diseases, cardiac markers, inflammation, and hormonal health. Jiangchuan utilizes advanced protein expression and hybridoma platforms to ensure their reagents meet the high sensitivity and specificity requirements of modern diagnostic platforms like chemiluminescence and lateral flow. The company serves a global clientele of diagnostic kit manufacturers, positioning itself as a key upstream player in the healthcare diagnostics supply chain. By focusing on core raw material innovation, Jiangchuan supports the advancement of rapid and accurate clinical testing worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangchuan Biotechnology.